Results 31 to 40 of about 41,893 (308)

Minimally Invasive Treatment of Benign Thyroid Nodules

open access: yesКреативная хирургия и онкология, 2022
Background. Nodular goitre is the commonest pathology of thyroid gland. According to published evidence, the endemic prevalence of iodine deficiency varies within 19–76 % population.
G. T. Gumerova   +4 more
doaj   +1 more source

Percutaneous Sclerotherapy of Venous Malformations of the Hand: A Multicenter Analysis

open access: yesCardiovascular and Interventional Radiology, 2021
To evaluate the safety and outcome of percutaneous sclerotherapy for treating venous malformations (VMs) of the hand. A retrospective multicenter trial of 29 patients with VMs primarily affecting the hand, including wrist, carpus, and/or fingers, treated
V. Schmidt   +11 more
semanticscholar   +1 more source

Comparison of outcomes and costs of surgery versus sclerotherapy to treat hydrocele

open access: yesEinstein (São Paulo), 2021
Objective: To evaluate the outcomes and costs associated with surgery versus sclerotherapy as treatment of hydroceles. Methods: A total of 53 men consecutively treated for hydrocele at our organization, between December 2015 and June 2019, were ...
Fernando Korkes   +4 more
doaj   +2 more sources

Music Therapy for Pediatric Pain Management During Bedside Sclerotherapy

open access: yesJournal of Vascular Anomalies, 2023
The management of pain is one of the primary concerns when administering sclerotherapy in children with vascular malformations. However, there is currently no standard of care and limited data regarding the effective treatment of pain associated with ...
Sheryl Tulin-Silver, MD   +2 more
doaj   +1 more source

Pharmacology of Sclerotherapy [PDF]

open access: yesSeminars in Interventional Radiology, 2010
Sclerotherapy is the therapeutic use of sclerosants in the controlled destruction of undesired target tissues. Sclerosants have been used in vascular and nonvascular settings, both as primary and adjunctive therapy. Effective sclerotherapy requires a conceptual understanding of key questions about the process being treated, including the method of ...
Kimi L. Kondo, Giustino Albanese
openaire   +3 more sources

FOAM SCLEROTHERAPY IN THE TREATMENT OF AXIAL VS COLLATERAL VARICOSITIES.

open access: yesStudent's Journal of Health Research Africa, 2023
Introduction: Varicose veins are one of the most common distressing situations, affecting almost 30-50% of the adult population. Patients experience throbbing pain, heaviness of the limb, bleeding on trivial trauma, and even ulceration.
Himadri Sekhar Kar, Sumitava Pachal
doaj   +1 more source

Sclerotherapy: step by step – liquid sclerotherapy

open access: yesАмбулаторная хирургия, 2020
Classic sclerotherapy using drugs in the native (liquid) state is almost the oldest method of minimally invasive treatment of various forms of varicose veins of lower extremities and not only.
V. Yu. Bogachev, V. N. Lobanov
doaj   +1 more source

Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohort

open access: yesEuropean Journal of Pediatrics, 2020
This retrospective study examines the outcomes of sclerotherapy in children with (veno)lymphatic malformations who received sclerotherapy between 2011 and 2016 (116 children, 234 procedures).
Frédérique C. M. Bouwman   +6 more
semanticscholar   +1 more source

Lymphangiography to treat postoperative lymphatic leakage: a technical review. [PDF]

open access: yes, 2014
In addition to imaging the lymphatics and detecting various types of lymphatic leakage, lymphangiography is a therapeutic option for patients with chylothorax, chylous ascites, and lymphatic fistula.
Kim, Soo Hwan   +5 more
core   +1 more source

Sclerotherapy for Venous Malformations of Head and Neck: Systematic Review and Meta-Analysis

open access: yesNeurointervention, 2020
We performed a systematic review and meta-analysis of studies performing sclerotherapy for treatment of venous malformations (VMs) of the face, head and neck.
Lucio de Maria   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy